Vita 34 AG (XTER:V3V) Change In Receivables : €-5.92 Mil (TTM As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Vita 34 AG Change In Receivables?

Vita 34 AG's change in receivables for the quarter that ended in Sep. 2023 was €-2.43 Mil. It means Vita 34 AG's Accounts Receivable increased by €2.43 Mil from Jun. 2023 to Sep. 2023 .

Vita 34 AG's change in receivables for the fiscal year that ended in Dec. 2022 was €-3.13 Mil. It means Vita 34 AG's Accounts Receivable increased by €3.13 Mil from Dec. 2021 to Dec. 2022 .

Vita 34 AG's Accounts Receivable for the quarter that ended in Sep. 2023 was €13.01 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Vita 34 AG's Days Sales Outstanding for the three months ended in Sep. 2023 was 58.15.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Vita 34 AG's liquidation value for the three months ended in Sep. 2023 was €-116.33 Mil.

Vita 34 AG Change In Receivables Historical Data

The historical data trend for Vita 34 AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita 34 AG Change In Receivables Chart

Vita 34 AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

1.16

0.27

-0.28

0.60

-3.13

Vita 34 AG Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Receivables	Get a 7-Day Free Trial															-	-1.41	-0.92	-1.17	-2.43

Vita 34 AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-5.92 Mil.

Vita 34 AG (XTER:V3V) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Vita 34 AG's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	13.009	/	20.413	*	91
=	58.15

2. In Ben Graham's calculation of liquidation value, Vita 34 AG's accounts receivable are only considered to be worth 75% of book value:

Vita 34 AG's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	10.415	-	138.16	+	0.75 * 13.009	+	0.5 * 3.317
=	-116.33

Vita 34 AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Vita 34 AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Vita 34 AG (XTER:V3V) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vita 34 AG (XTER:V3V) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

V3V:Germany V3V:Germany V3V:Germany

Address

Deutscher Platz 5a, Leipzig, DEU, D-04103

Website

https://www.vita34.de

Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group's reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34. It operates in Germany, Spain, and other international countries, of which maximum revenue is derived from the business operations in Germany.

Executives

Jakub Julian Baran	Member of the Management Board
Dr. Alexander Granderath	Supervisory Board

Vita 34 AG (XTER:V3V) Headlines

No Headlines